JWA
JAZZ icon

JFS Wealth Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

JFS Wealth Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.5K Buy
56
+1
+2% +$219 ﹤0.01% 882
2026
Q1 		$10.4K Buy
55
+4
+8% +$699 ﹤0.01% 936
2025
Q4 		$8.67K Buy
51
+24
+89% +$3.68K ﹤0.01% 1036
2025
Q3 		$3.56K Buy
27
+1
+4% +$120 ﹤0.01% 1247
2025
Q2 		$2.76K Sell
26
-23
-47% -$2.5K ﹤0.01% 1297
2025
Q1 		$6.08K Sell
49
-6
-11% -$783 ﹤0.01% 1041
2024
Q4 		$6.77K Buy
55
+8
+17% +$943 ﹤0.01% 997
2024
Q3 		$5.24K Buy
47
+2
+4% +$219 ﹤0.01% 1104
2024
Q2 		$4.8K Hold
45
– – ﹤0.01% 1078
2024
Q1 		$5.42K Buy
45
+8
+22% +$980 ﹤0.01% 1067
2023
Q4 		$4.55K Buy
37
+8
+28% +$998 ﹤0.01% 1098
2023
Q3 		$3.75K Sell
29
-6
-17% -$799 ﹤0.01% 1115
2023
Q2 		$4.34K Sell
35
-6
-15% -$807 ﹤0.01% 1066
2023
Q1 		$6K Buy
41
+5
+14% +$740 ﹤0.01% 914
2022
Q4 		$5.74K Sell
36
-1
-3% -$147 ﹤0.01% 936
2022
Q3 		$5K Sell
37
-3
-8% -$456 ﹤0.01% 984
2022
Q2 		$6K Buy
40
+4
+11% +$616 ﹤0.01% 939
2022
Q1 		$6K Buy
36
+23
+177% +$3.34K ﹤0.01% 977
2021
Q4 		$2K Buy
+13
New +$1.71K ﹤0.01% 1094

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

JFS Wealth Advisors's JAZZ Position: Q2 2026 in Review

JFS Wealth Advisors increased its Jazz Pharmaceuticals (JAZZ) stake by 1.8% in Q2 2026, buying an estimated $219 and bringing the position to 56 shares worth $13.5K. The position accounts for ﹤0.01% of the portfolio, ranked #882.

JFS Wealth Advisors first reported a position in JAZZ in Q4 2021 and has held it in 19 quarters since. 641 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • JFS Wealth Advisors held 56 shares of Jazz Pharmaceuticals worth $13.5K as of Q2 2026.
  • JFS Wealth Advisors bought 1 Jazz Pharmaceuticals share in Q2 2026, an estimated $219.
  • Jazz Pharmaceuticals made up ﹤0.01% of JFS Wealth Advisors's portfolio in Q2 2026, its #882 holding.
  • JFS Wealth Advisors first reported a position in Jazz Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • 641 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on JFS Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.